Aurobindo Pharma share news, announcements and annual reports
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Aurobindo Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Jul 2000 on NSE
Last close ₹1,659.90up ₹15.10 (0.92%)BSE ₹1,655.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,644.80.
29 Oct: open ₹1,643.00, high ₹1,659.90, low ₹1,635.10
52-week range of traded prices to 29 Oct 2026
₹1,091.20Low, 30 Oct 2025₹1,740.00High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹95,507 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.73
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.52
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,10,88155.8% delivered
Aurobindo Pharma orders, deals and press releases
463 filed, newest first. Page 10 of 10.
Mar 2007
29 Mar · Business
Press release dated March 29, 2007, titled "Cephazone, cephalosporin sterile injectable facility in California, is approved by USFDA and receives approval of Ceftriaxone from USFDA". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Mar · Business
Press release dated March 09, 2007, titled "Aurobindo receives US FDA Final approval For Didanosine Oral Suspension". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2007
28 Feb · Business
Press release, dated February 28, 2007, titled "Aurobindo receives NAM Finland Approval for its facility at UNIT - VI". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Feb · Business
Press release, dated February 21, 2007, titled "Aurobindo's debut in Botswana is with 9 products in one go". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Feb · Business
The equity shareholders of the Company at their Court Convened Meeting held on February 20, 2007, have approved the Scheme of Arrangement ("the Scheme") for the merger of APL Life Sciences Ltd ("APL Life") and Senor Organics Pvt Ltd ("Senor"), both being wholly owned subsidiaries of the Company, with itself and the utilization of the Securities Premium account pursuant to the provision of Sections 391 to 394 read with Sections 78 and Sections 100 to 103 and other applicable provisions of the Companies Act, 1956 with the requisite majority. The appointed date of the Scheme of Arrangement is April 01, 200620 Feb · Business
Press release dated February 20, 2007, titled "Aurobindo receives seventh approval from MCC South Africa". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Feb · Business
Press release, dated February 02, 2007, titled "Aurobindo's tally of USFDA approved cephs goes up." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
31 Jan · Business
Press release, dated January 31, 2007, titled "Aurobindo Pharma's growth momentum continues. Net Profit, EBITDA, Revenues grew by 130%, 58% & 33% respectively." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jan · Business
Press release dated January 30,2007, titled "Aurobindo receives USFDA nod for its facility at UNIT-VI". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jan · Business
Company had filed a company application with the Hon'ble High Court of Judicature of Andhra Pradesh at Hyderabad on January 03,2007. Subsequently, the Hon'ble High Court, by an order made on January 05,2007 (order received on January 18,2007) has directed that a meeting of the Equity Shareholders of the Company be convened and held on February 20,2007 for the purpose of considering, and if thought fit, approving with or without modification(s), the Scheme of Arrangement between Aurobindo Pharma Limited and APL Life Sciences Limited and Senor Organics Private Limited and their respective shareholders.29 Jan · Business
Press release dated January 29,2007, titled "Aurobindo bags one more cephalosporin from USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Business
Press release dated January 18, 2007, titled "Aurobindo receives 36th USFDA approval". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Jan · Business
Press release dated January 02, 2007, titled "Aurobindo receives two more USFDA approvals". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.